Search | Clinical Trials Finder

These results were retrieved from the live ClinicalTrials.gov registry. Filters and sort order apply to this result list.

ClinicalTrials.gov public records Last synced Nov 9, 2026, 3:07 PM EST

All trial information on this site comes from the official ClinicalTrials.gov public API (clinicaltrials.gov/api/v2), run by the U.S. National Library of Medicine. We only display that public information; we do not add opinions, endorsements, or any other intent. Always review the official ClinicalTrials.gov record for the latest information.

Showing 313–336 of 1,257 matching trials from the live ClinicalTrials.gov search.

Filters: Condition: Local Disease Clear all

Conditions: Solid Tumor
Interventions: High-Dose Conformal Radiation Therapy, Pembrolizumab; Radiation · Drug
Lead sponsor: James Larner, MD; Other
Eligibility: 18 Years and older
Enrollment: 21 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2017 – 2020
U.S. locations: 1
States / cities: Charlottesville, Virginia

Conditions: Lung Cancer
Interventions: Bupivacaine, Bupivacaine liposome; Drug
Lead sponsor: Icahn School of Medicine at Mount Sinai; Other
Eligibility: 18 Years to 75 Years
Enrollment: 65 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: 2018
U.S. locations: 2
States / cities: New York, New York

Conditions: Psoriasis Vulgaris, Psoriasis
Interventions: tofacitinib ointment 20 mg/g, tofacitinib ointment 10 mg/g, placebo ointment (vehicle); Drug
Lead sponsor: Pfizer; Industry
Eligibility: 18 Years and older
Enrollment: 476 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2013 – 2014
U.S. locations: 29
States / cities: Hot Springs, Arkansas • Bakersfield, California • Irvine, California + 22 more

Conditions: Chronic Neuropathic Pain, Post-Stroke Pain, Trigeminal Neuralgia, Nerve Injury, Spinal Cord Injuries, Pain, Postoperative, Complex Regional Pain Syndromes, Post-herpetic Neuralgia, Nerve Root Avulsion
Interventions: High Frequency rTMS, Low Frequency rTMS; Device
Lead sponsor: University of California, San Francisco; Other
Eligibility: 18 Years to 80 Years
Enrollment: 32 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2022 – 2026
U.S. locations: 1
States / cities: San Francisco, California

Conditions: Cardiac Arrest
Interventions: Non-invasive cerebral flow monitoring; Device
Lead sponsor: Icahn School of Medicine at Mount Sinai; Other
Eligibility: 18 Years and older
Enrollment: 21 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2015 – 2016
U.S. locations: 1
States / cities: New York, New York

Conditions: Coronary Disease, Coronary Artery Disease, Coronary Restenosis
Interventions: Not listed
Lead sponsor: Abbott Medical Devices; Industry
Eligibility: 18 Years and older
Enrollment: 697 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2004 – 2009
U.S. locations: 22
States / cities: Phoenix, Arizona • San Jose, California • Stanford, California + 18 more

Conditions: Autonomic Peripheral Nervous System Diseases
Interventions: [18F]4F-MHPG, [18F]3F-PHPG; Drug
Lead sponsor: University of Michigan; Other
Eligibility: 18 Years to 55 Years
Enrollment: 16 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: 2015 – 2016
U.S. locations: 1
States / cities: Ann Arbor, Michigan

Conditions: Regional Block for Pain Control, Supraclavicular Block, Ultrasound Guided Block, Block Additive
Interventions: Buprenorphine; Drug
Lead sponsor: University of Wisconsin, Madison; Other
Eligibility: 18 Years to 79 Years
Enrollment: 26 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2012 – 2015
U.S. locations: 1
States / cities: Madison, Wisconsin

Conditions: Pain, Postoperative
Interventions: Bupivacaine Injection; Drug
Lead sponsor: Northwell Health; Other
Eligibility: 18 Years and older · Female only
Enrollment: 129 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: 2021 – 2023
U.S. locations: 1
States / cities: Manhasset, New York

Conditions: Drug Reaction to Analgesic Nos
Interventions: RX0041 4%, Placebo, RX0041 8%; Drug
Lead sponsor: Pharmaceutical Project Solutions, Inc.; Industry
Eligibility: 18 Years and older
Enrollment: 648 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2014 – 2016
U.S. locations: 2
States / cities: Mount Arlington, New Jersey • Columbia, South Carolina

Conditions: Anxiety, Pain
Interventions: Virtual Reality with Oculus Go headset; Device
Lead sponsor: Cedars-Sinai Medical Center; Other
Eligibility: 18 Years to 64 Years
Enrollment: 80 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: 2027 – 2028
U.S. locations: 1
States / cities: Los Angeles, California

Conditions: Breast Cancer
Interventions: 3D-Conformal External Beam; Radiation
Lead sponsor: Radiation Therapy Oncology Group; Network
Eligibility: 18 Years to 120 Years · Female only
Enrollment: 65 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2010 – 2022
U.S. locations: 57
States / cities: Peoria, Arizona • Burbank, California • Aurora, Colorado + 44 more

Conditions: Drug Toxicity
Interventions: HIE-Enhanced Medication Reconciliation, Optimal Medication Reconciliation without HIE; Other
Lead sponsor: VA Office of Research and Development; Federal
Eligibility: 18 Years and older
Enrollment: 402 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2012 – 2016
U.S. locations: 1
States / cities: The Bronx, New York

Conditions: Breast Cancer
Interventions: Molecular Breast Imaging (MBI), Tc99m sestamibi; Procedure · Drug
Lead sponsor: M.D. Anderson Cancer Center; Other
Eligibility: 18 Years and older · Female only
Enrollment: 96 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2015 – 2028
U.S. locations: 1
States / cities: Houston, Texas

Conditions: Parkinson Disease
Interventions: collection of LFPs; Other
Lead sponsor: Rush University Medical Center; Other
Eligibility: 30 Years to 80 Years
Enrollment: 9 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2020
U.S. locations: 1
States / cities: Chicago, Illinois

Conditions: General Anesthesia, Surgeries Requiring A Minimum One Day Hospitalization, Elderly
Interventions: Lidocaine; Drug
Lead sponsor: Cedars-Sinai Medical Center; Other
Eligibility: 65 Years and older
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2011 – 2015
U.S. locations: 1
States / cities: Los Angeles, California

Conditions: Osteoarthritis, Knee
Interventions: Liposomal bupivacaine, Standard of Care; Drug
Lead sponsor: OhioHealth; Other
Eligibility: 18 Years and older
Enrollment: 60 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2014 – 2016
U.S. locations: 1
States / cities: Columbus, Ohio

Conditions: Inflammation, Burns, Ulcers
Interventions: Mepilex Border Ag; Device
Lead sponsor: Molnlycke Health Care AB; Industry
Eligibility: 18 Years and older
Enrollment: 27 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2010 – 2011
U.S. locations: 3
States / cities: Momtgomery, Alabama • Iowa City, Iowa • The Bronx, New York

Conditions: Anesthetic Effectiveness
Interventions: Mandibular buccal Infiltration injection; Procedure
Lead sponsor: Ohio State University; Other
Eligibility: 18 Years to 65 Years
Enrollment: 60 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: 2012 – 2013
U.S. locations: 1
States / cities: Columbus, Ohio

Conditions: Depression
Interventions: ABP688; Drug
Lead sponsor: Novartis Pharmaceuticals; Industry
Eligibility: 55 Years to 80 Years
Enrollment: 42 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: 2008 – 2010
U.S. locations: 2
States / cities: New York, New York • Pittsburgh, Pennsylvania

Conditions: Complex Regional Pain Syndrome, Type I
Interventions: lenalidomide, Placebo; Drug
Lead sponsor: Celgene Corporation; Industry
Eligibility: 18 Years and older
Enrollment: 184 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2005 – 2008
U.S. locations: 27
States / cities: Peoria, Arizona • La Jolla, California • Loma Linda, California + 23 more

Conditions: Localized Resectable Neuroblastoma, Localized Unresectable Neuroblastoma, Neurotoxicity Syndrome, Pain, Regional Neuroblastoma, Stage 4 Neuroblastoma, Stage 4S Neuroblastoma
Interventions: Cytology Specimen Collection Procedure, Pharmacological Study; Other
Lead sponsor: National Cancer Institute (NCI); NIH
Eligibility: Up to 15 Years
Enrollment: 12 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: Started 2011
U.S. locations: 1
States / cities: Philadelphia, Pennsylvania

Conditions: Post-operative Pain
Interventions: Bupivacaine / Lidocaine, Lidocaine; Drug
Lead sponsor: Baylor Research Institute; Other
Eligibility: 18 Years and older
Enrollment: 350 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2008 – 2018
U.S. locations: 1
States / cities: Dallas, Texas

Conditions: Lipodystrophy
Interventions: Not listed
Lead sponsor: National Center for Research Resources (NCRR); NIH
Eligibility: 18 Years to 65 Years · Female only
Enrollment: 12 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: Started 1999
U.S. locations: 1
States / cities: Galveston, Texas

Search by objective public record fields.

HDCRT Plus Pembrolizumab in Advanced Malignancies

Efficacy Between Serratus Plane Block And Local Infiltration In Vats

Tofacitinib Ointment For Chronic Plaque Psoriasis

Transcranial Magnetic Stimulation for Chronic Neuropathic Pain

Non Invasive Neuromonitoring After Cardiac Arrest

PROSPECT: An Imaging Study in Patients With Unstable Atherosclerotic Lesions

Clinical Translation of 18F-Labeled Hydroxyphenethylguanidines

Duration of Analgesic Effect for Ultrasound Guided Supraclavicular Blocks With the Addition of Buprenorphine to Local Anesthetic Solution

Pre-incision Versus Post-incision Local Anesthetic During Robotic Sacrocolpopexy

Topical Anesthetic for Procedures Through the Nose

The Role of Virtual Reality During Regional Anesthesia

Radiation Therapy in Treating Women With Locally Recurrent Breast Cancer Previously Treated With Repeat Breast-Preserving Surgery

Regional Data Exchange to Improve Medication Safety

Tc99m Sestamibi Molecular Breast Imaging

High Order Spectral Analysis of Local Field Potential Data on a Subgroup of Parkinson's Disease Patients Who Are Carriers of Mutations in the Glucocerebrosidase (GBA) Gene Undergoing DBS Electrode Placement

How Lidocaine Affects Outcomes In Orthopedic Surgery Patients

Liposomal Bupivacaine Versus Standard of Care in Total Knee Surgery

Open Multi-centre Investigation to Evaluate Signs and Symptoms of Local Inflammation/Infection on Chronic Ulcers and Partial Thickness Burns When Using Mepilex Border Ag as an Anti-microbial Wound Dressing

Testing the Anesthetic Effectiveness of Three Different Dental Local Anesthetics Injected Next to a Lower First Molar

Characterize the Regional Distribution of [11C] ABP688 in Brain by Positron Emission Tomography (PET)

Study to Evaluate the Efficacy and Safety of Lenalidomide in the Treatment of Complex Regional Pain Syndrome Type 1

Pharmacokinetics of Ch14.18 in Younger Patients With High-Risk Neuroblastoma

A Trial Assessing The Association Between Type Of Local Anesthesia Treatment And Postoperative Pain In Patients In Having Undergone Arrhythmia Surgery

Study of Alpha-2 Adrenergic Receptor Dysfunction in Regional Lipoatrophy